Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

CHRS Coherus BioSciences PE ratio, current and historical analysis

The current P/E ratio of CHRS cannot be calculated, as the latest EPS of -$1.13 is negative. Coherus BioSciences's last PE ratio on record was 5.52 in December 2024.

CHRS PE ratio history

How has CHRS's PE ratio performed in the past

The mean historical PE ratio of Coherus BioSciences over the last six years is 8.62. Analyzing the last six years, CHRS's PE ratio reached its highest point in the Dec 2019 quarter at 13.96, with a price of $18.01 and an EPS of $1.29. The Dec 2024 quarter saw the lowest point at 5.52, with a price of $1.38 and an EPS of $0.25.

Today
N/A
Average
8.62
Median
7.94
Minimum
5.52
Maximum
13.96

Coherus BioSciences PE ratio by year

Maximum annual decrease: -32.74% in 2020

Year PE ratio PE change Price EPS
2024 5.52 N/A $1.38 $0.25
2023 N/A N/A $3.33 -$2.53
2022 N/A N/A $7.92 -$3.76
2021 N/A N/A $15.96 -$3.81
2020 9.39 -32.74% $17.38 $1.85
2019 13.96 N/A $18.01 $1.29
2018 N/A N/A $9.05 -$3.22
2017 N/A N/A $8.8 -$4.48
2016 N/A N/A $28.15 -$3.04
2015 N/A N/A $22.96 -$6.01
2014 N/A N/A $16.32 -$10.64
2013 N/A N/A N/A -$16.1
2012 N/A N/A N/A -$15.85

Coherus BioSciences PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 N/A N/A $0.81 -$1.13
Dec 2024 5.52 N/A $1.38 $0.25
Sep 2024 N/A N/A $1.04 -$0.03
Jun 2024 N/A N/A $1.73 -$0.35
Mar 2024 N/A N/A $2.39 -$0.73
Dec 2023 N/A N/A $3.33 -$2.53
Sep 2023 N/A N/A $3.74 -$2.62
Jun 2023 N/A N/A $4.27 -$3.32
Mar 2023 N/A N/A $6.84 -$3.48
Dec 2022 N/A N/A $7.92 -$3.76
Sep 2022 N/A N/A $9.61 -$3.59
Jun 2022 N/A N/A $7.24 -$2.97
Mar 2022 N/A N/A $12.91 -$2.72
Dec 2021 N/A N/A $15.96 -$3.81
Sep 2021 N/A N/A $16.07 -$3.13

CHRS Price vs fair value

How does CHRS's price compare to its estimated fair value based on its growth

CHRS average PE ratio chart

What is the average PE ratio of CHRS for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
8.62
15-year avg
N/A

CHRS PE vs peers

What is CHRS's PE ratio compared to its peers
Stock name PE ratio Market cap
AMGN Amgen Inc 25.97 $154.33B
RGEN Repligen Corp N/A $7.11B
AGEN Agenus Inc N/A $154.36M
SRPT Sarepta Therapeutics Inc N/A $3.89B
CHRS Coherus BioSciences Inc N/A $92.4M

Frequently asked questions

What is Coherus BioSciences's PE ratio?

The current price to earnings ratio of CHRS cannot be determined, as its EPS of -$1.13 is negative.

What is the highest PE ratio for CHRS?

The highest quarterly PE ratio in the last six years has been 13.96 and it was in the Dec 2019 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.